Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ERBB3 |
| Variant | V714M |
| Impact List | missense |
| Protein Effect | no effect |
| Gene Variant Descriptions | ERBB3 (HER3) V714M lies within the protein kinase domain of the Erbb3 (Her3) protein (UniProt.org). V714M demonstrates growth promotion and transforming ability in the presence of Erbb2 (Her2) similar to wild-type Erbb3 (Her3) in culture (PMID: 23680147). |
| Associated Drug Resistance | |
| Category Variants Paths |
ERBB3 mutant ERBB3 V714M |
| Transcript | NM_001982.4 |
| gDNA | chr12:g.56096587G>A |
| cDNA | c.2140G>A |
| Protein | p.V714M |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001982 | chr12:g.56096587G>A | c.2140G>A | p.V714M | RefSeq | GRCh38/hg38 |
| NM_001982.3 | chr12:g.56096587G>A | c.2140G>A | p.V714M | RefSeq | GRCh38/hg38 |
| NM_001982.4 | chr12:g.56096587G>A | c.2140G>A | p.V714M | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| ERBB3 V714M | Advanced Solid Tumor | sensitive | Trastuzumab | Preclinical - Cell culture | Actionable | In a preclinical study, Herceptin (trastuzumab) inhibited cell proliferation in transformed cell lines expressing ERBB3 (HER3) V714M in culture (PMID: 23680147). | 23680147 |
| ERBB3 V714M | Advanced Solid Tumor | sensitive | Pertuzumab | Preclinical - Cell culture | Actionable | In a preclinical study, Perjeta (pertuzumab) inhibited cell proliferation in transformed cell lines expressing ERBB3 (HER3) V714M in culture (PMID: 23680147). | 23680147 |
| ERBB3 V714M | Advanced Solid Tumor | sensitive | Lapatinib | Preclinical - Cell culture | Actionable | In a preclinical study, Tykerb (lapatinib) inhibited cell proliferation in transformed cell lines expressing ERBB3 (HER3) V714M in culture (PMID: 23680147). | 23680147 |